Singapore: Cellmid completed its first in-life diabetic nephropathy study with two of its anti-midkine antibodies (MK-Ab...
Singapore: Australia has acknowledged its bioscience innovators and companies through an industry excellence awards orga...
Singapore: Researchers have found a new variant of a gene that can confer five-fold protection against typhoid fever. Th...
Singapore: Medical device industry is a complex one and even more complex is the regulatory landscape of the sector, ech...
Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has f...
Singapore: Agilent Technologies has launched Spectroscopy Technology Innovation Center in Mulgrave, Australia, with an i...
Singapore: Cantrixil, a first-in-class experimental chemotherapeutic, developed by Australia/US-based biotech firm Novog...
Singapore: Auspherix, an early stage anti-infectives company developing novel antibiotics to treat resistant bacterial d...
Singapore: Australia and Switzerland based Clinuvel Pharmaceuticals' Singapore subsidiary Vallaurix has successfully com...
Singapore: Australia's Medical Research Commercialisation Fund (MRCF) has invested around $1 million in an early stage a...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has achieved successful result ...
Eminent pain researcher Professor Maree Smith is a very good example of an academician, who turned towards the industry ...
Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countr...
Singapore: New Zealand-based Ebos Group is going to buy Australia's pharmaceutical wholesaler and distributor, Symbion t...
Singapore: New research has uncovered a mechanism that regulates the reproduction of plants, providing a possible tool f...
Singapore: AIDS 2014, the 20th International AIDS Conference ended in Melbourne, Australia today with a chorus of intern...
Singapore: Australian firm, Admedus, has achieved positive endpoint in its phase I trial of a therapeutic vaccine for H...
Singapore: Type 2 diabetes treatment market in Asia-Pacific (APAC) will rise in value from an estimated $6.5 billion in ...
